This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—I have read with interest the editorial on galactose in The Journal, September 3. From your editorial based on the report of Roe and Schwartzmann (J. Biol. Chem.96:717 [June] 1932), one gathers that galactose is as well tolerated by diabetic patients as by normal individuals and may be used as a source of energy by diabetic patients with less harm than dextrose. I cannot subscribe to these assumptions.The experiments of Mann and his co-workers following complete liver extirpation in dogs have shown the importance of available blood sugar in the maintenance of life. When they injected dextrose into the blood stream of an animal moribund because of the hypoglycemic state following hepatectomy, recovery was usually complete in from one to four minutes. However, the beneficial action of a like amount of galactose, similarly administered, was so slight and transient that its effect could scarcely
Shay H. GALACTOSE FOR DIABETIC PATIENTS. JAMA. 1932;99(21):1799. doi:10.1001/jama.1932.02740730063031
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: